DreaMed
PrivateLast Round
Early Funding
Aug 19, 2024
Total Funding Raised
$27.36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DreaMed operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was an Early Funding round in August 2024.
DreaMed is a health technology company that provides an AI-based clinical decision support system for diabetes management to optimize insulin therapy.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, EHR & EMR, Medical Devices
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DreaMed Comparables
Compare DreaMed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Diasyst | 88% | |
| Mellitus Health, Inc. | 86% | |
| OneTwo Analytics AB | 84% |
For institutional investors. Book with your work email.
DreaMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 19, 2024 | ||||
| Grant | Feb 23, 2023 | ||||
| Grant | Nov 24, 2020 | ||||
| Grant | Aug 10, 2020 | ||||
| Series A | Jul 25, 2016 | ||||
Grant | Feb 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DreaMed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Millhouse LLC | Series A |
| eHealth Ventures | Early Funding |
| Helmsley Charitable Trust | Grant |
| Medtronic | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 429% MoM, reaching 2.9K.
- Feb 1, 2016
Secured $4M from Helmsley Charitable Trust
For institutional investors. Book with your work email.
DreaMed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DreaMed's valuation, stock price, and market status.
Is DreaMed a public or private company?
DreaMed is a private company.
What is the current stock price of DreaMed?
DreaMed is a private company, so its shares have no public market price. Caplight tracks DreaMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DreaMed worth (valuation)?
Valuation information for DreaMed is not publicly available.
Can I buy DreaMed stock?
DreaMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DreaMed's last funding round?
DreaMed's most recent funding round was Early Funding on August 19, 2024.
Who are the main investors in DreaMed?
Key investors in DreaMed include eHealth Ventures, Helmsley Charitable Trust, Medtronic.
Will DreaMed IPO soon?
No public IPO plans have been announced for DreaMed.
How can I track DreaMed secondary market activity?
Caplight tracks bids, offers, and trades in DreaMed's shares on secondary markets.